Navigation Links
Task Force Alerting Nevadans to 'Silent' Killer Disease Crisis
Date:2/17/2009

e 'silent phase' of the disease. The only way to know if you have the disease is to get some simple medical tests. If CKD is detected early, you may be able to prevent kidney damage."

Getting tested is a positive step towards keeping your kidneys healthy. If you have diabetes, high blood pressure, cardiovascular disease, a family history of kidney disease or are age 60 or over the National Kidney Foundation suggests you talk to your doctor about being screened for kidney disease.

HealthInsight, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services, supports hospitals, physician offices, nursing homes, home health agencies, and health insurance purchasers in achieving healthcare excellence through a wide range of services aimed at improving quality and providing safe, effective, and efficient care. For more information or links to Medicare data and other resources, visit www.healthinsight.org.

This material was prepared by HealthInsight, the Medicare Quality Improvement Organization for Nevada and Utah, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS policy.


'/>"/>
SOURCE HealthInsight
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Force Tester Shoulders The Burden
2. Nationwide Receives IBI/NBCH Healthy Workforce Productivity Award
3. Video: Women in the Workforce Link Cosmetic Surgery to Success
4. Bayer Consumer Care Joins Forces with WomenHeart to Fight Heart Disease
5. KV Pharmaceutical Company Reduces Workforce
6. Unbelievable Lack Of Marketing Knowledge Forces Doctors To Quit Practice.
7. The Leukemia & Lymphoma Society and Womens Running Magazine Join Forces to Launch New All-Women Half Marathon in St. Petersburg
8. National Front Line Caregiver Group Urges Senate Leaders to Support Grassley Amendment Protecting Seniors Care, Assuring Stability of Nations Long Term Care Workforce
9. New Coalition, the Eldercare Workforce Alliance, to Address the Critical Shortage of Healthcare Workers Capable of Meeting the Unique Care Needs of Older Adults
10. Neovasc Receives CE Mark Approval for Peripatch(TM) Aegis Staple Line Reinforcement Product
11. Press Ganey and Harvards Forces of Change Announce 2nd Annual Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... information and Treatment site www.sleeping-with-a-sleeping-disorder.com is ... herbal or natural sleep aids from around the ... a good cause. The submissions will be compiled ... ,Encyclopedia, by YOU, to be sold from the ... donate 100% of the proceeds ,from sales of ...
(Date:12/5/2009)... There have been significant scientific advances in the field ... a better understanding of how certain diseases progress in ... with the best care. Research presented today at the ... explores optimal induction therapies for managing multiple myeloma, the ...
(Date:12/5/2009)... 5 Leukemia and myeloproliferative disorders are serious ... at the 51st Annual Meeting of the American ... and improved diagnostic methods for patients suffering from ... lymphoblastic leukemia, and myelofibrosis that are based on ...
(Date:12/5/2009)... International Solutions, an innovative new international private medical insurance plan which ... to offering customers the flexibility to add or remove a wide ... enables customers to tailor their benefits to complement those already offered ... ...
(Date:12/4/2009)... (NYSE: CRE ) ("Care" or the "Company") today ... $0.17 per share of common stock. The dividend is payable ... 14, 2009. ,, About Care Investment Trust ... and finance company investing in healthcare-related real estate and commercial mortgage ...
Breaking Medicine News(10 mins):Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... 13 most prevalent serotypes associated with pneumococcal disease -COLLEGEVILLE, ... division of Wyeth (NYSE: WYE ), announced ... (BLA) to the U.S. Food and Drug Administration (FDA) ... Protein). Last year, the FDA granted Prevnar 13 ...
... makes children more comfortable and parents more confident, according ... Journal of Clinical Nursing . , Researchers from ... 112 children before and after nurses on two paediatric ... uniforms. The children, who had an average age of ...
... - Approximately $256 Million in Net Proceeds Raised in a Follow-on Offering ... Receives Award for Best R&D Lease in ... Area - - Zoning Approved for ... Science Venue and Ensures Cambridge,s Position as an Epicenter of the Life ...
... reported today that it has completed the previously announced amendment of its credit ... , An increase in the debt ... , A decrease in the interest coverage ... A decrease in the minimum risk based capital ...
... www.mtscorp.com , today appointed Rob Rebak as the company,s new Chief ... and specializes in connecting engaged health consumers with health brands. ... going forward, and also for building upon the company,s strong financial ... ...
... International partnership expands AMICAS, footprint in the ... (Nasdaq: AMCS ), a leader ... management solutions, today announced an exclusive partnership ... AMICAS PACS(TM), AMICAS Reach(TM), and AMICAS RadStream(TM) ...
Other Medicine News:Health News:Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers 2Health News:Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers 3Health News:Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers 4Health News:Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers 5Health News:Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers 6Health News:Multi-colored uniforms improve perceptions of hospital nurses among children and parents 2Health News:Alexandria Real Estate Equities Provides Update 2Health News:Alexandria Real Estate Equities Provides Update 3Health News:Alexandria Real Estate Equities Provides Update 4Health News:Conseco Closes Amendment to Credit Facility 2Health News:Conseco Closes Amendment to Credit Facility 3Health News:Conseco Closes Amendment to Credit Facility 4Health News:Marketing Technology Solutions Primed for Future Growth with Appointment of Rob Rebak as New CEO 2Health News:Marketing Technology Solutions Primed for Future Growth with Appointment of Rob Rebak as New CEO 3Health News:Australia's Healthinc and AMICAS Announce Exclusive Partnership 2Health News:Australia's Healthinc and AMICAS Announce Exclusive Partnership 3
(Date:12/4/2009)... Inc. (NYSE: HSP ), a leading global ... launch of its next-generation 50 mL and 100 mL ... now offers a complete size range (50 mL to ... The launch of the 50 mL and 100 mL ...
(Date:12/4/2009)... 4 OrthoAccel Technologies, Inc., developers of the ... device to enhance orthodontics, announced the availability of ... PennWell Corporation , a leader in professional education ... The course focuses on patient views about orthodontic ...
(Date:12/4/2009)... AstraZeneca (NYSE: AZN ) today announced that ... once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as ... Depressive Disorder (MDD). SEROQUEL XR is the only medication ... both major depressive disorder as adjunctive therapy and acute ...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9University of Toronto helps to barcode the worlds plants 9394 1University of Toronto helps to barcode the worlds plants 9394 2Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 1Study shows cancer vaccines led to long term survival for patients with metastatic melanoma 9391 2Gloomy Days Dim Cognitive Powers of the Depressed 52961 1Gloomy Days Dim Cognitive Powers of the Depressed 52961 2
... is recommended for separations of DNA fragments ... that are easy to handle, and remains ... minimizes the risk of cracking or breaking. ... (GQT) products with similar sieving properties, is ...
... Agarose-HR™ High Resolution - ... from 50 to 1000 ... for sizing PCR fragments, ... by restriction enzyme digestion, ...
The reading of agglutinations process in Diana Reader is by image treatment which allows great sensitivity....
... designed for medium to ... centers and reference laboratories ... antibody screening. It will ... functions including blood group ...
Medicine Products: